<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03887598</url>
  </required_header>
  <id_info>
    <org_study_id>2019(S073)</org_study_id>
    <nct_id>NCT03887598</nct_id>
  </id_info>
  <brief_title>Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules</brief_title>
  <official_title>A Multi-center Study of Differential Diagnosis Breast Nodules by Ultrasound Artificial Intelligence and Ultrasound Elastography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xin-Wu Cui</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Taizhou Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Hospital of Traditional Chinese and Western Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Macheng People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huangshi Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Affiliated Hospital of Jiangsu University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The First People's Hospital of Yichang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Second People's Hospital of Yichang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangyang Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>the Second Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Anqing People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huainan People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wenzhou Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xuzhou First People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Central Hospital of Lishui City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Huai'an First People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>WISCO General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First People's Hospital of Jiangxia District, Wuhan City</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Enshi State Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lianyungang Third People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xiangyang First People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The application of computer-aided diagnosis (CAD) technology &quot;S-Detect&quot; enables qualitative
      and quantitative automated analysis of ultrasound images to obtain objective, repeatable and
      more accurate diagnostic results. The Elastic Contrast Index (ECI) technique, unlike
      conventional strain-elastic imaging techniques, can evaluate the elastic distribution in the
      region of interest. The purpose of the study was to evaluate the differential diagnosis value
      of ultrasound S-Detect technology for benign and malignant breast nodules and evaluate the
      differential diagnosis consistency of the ultrasound S-Detect technique and the examiner for
      benign and malignant breast nodules and explore the differential diagnosis value of Samsung
      ultrasound elastic contrast Index (ECI) technique for benign and malignant breast nodules.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer is the most common malignancy in women and the second leading cause of cancer
      deaths worldwide. Therefore, early detection of breast cancer and timely treatment are of
      great significance for controlling and reducing breast cancer mortality. Breast ultrasound is
      an adjunct to extensive use in the detection of breast cancer, but ultrasound is highly
      technically dependent on the examiner, and the results are greatly influenced by the
      subjective nature of the examiner, adding unnecessary surgery and puncture, which causes
      great problems for clinicians and patients.Moreover, the value of conventional ultrasound in
      the differential diagnosis of breast mass is still limited, and the emergence of new
      technologies such as artificial intelligence and elastography has improved the accuracy of
      ultrasound diagnosis to varying degrees.

      S-Detect technology is a computer-aided (CAD) system recently developed by Samsung Medical
      Center for breast ultrasound to assist in morphological analysis based on the Breast Imaging
      Reporting and Data System (BI-RADS) description and final assessment.This provides a new way
      to identify the benign and malignant breast nodules.

      The E-Breast technique, unlike conventional strain-elastic imaging technology, performs an
      elastic analysis of the entire two-dimensional image.Moreover, when measuring the elastic
      ratio, it is only necessary to place a region of interest (ROI) at the nodule.Compared with
      the average elasticity of the surrounding area, it is more reflective of the elastic ratio of
      the mass to the surrounding tissue.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2019</start_date>
  <completion_date type="Anticipated">February 18, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 18, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Benign or malignant lesions as determined by pathology</measure>
    <time_frame>Before surgery or biopsy</time_frame>
    <description>The pathological diagnosis of benign or malignant lesions from surgery samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Elastic ratio</measure>
    <time_frame>Before surgery or biopsy</time_frame>
    <description>Clear ECI value</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>breast nodule</arm_group_label>
    <description>Those with one or more breast nodules, age 18 or older, upcoming FNAB or surgery and signed informed consent.Those without adverse effects on the test or threatening other candidates, such as mental illness, pregnancy, poor ultrasound image quality, history of breast surgery or breast biopsy, simple cystic nodules, calcification, excessive mass or too small, the S-DetectTM system can not identify the boundary of the tumor, the basic information is incomplete.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound diagnosis</intervention_name>
    <description>Ultrasound diagnosis of lesions with Samsung S-Detect and ECI technology</description>
    <arm_group_label>breast nodule</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with breast nodules in large tertiary hospitals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Had breast lesions detected by ultrasound

          2. Age 18 or older

          3. Upcoming FNAB or surgery

          4. Signing informed consent

        Exclusion Criteria:

          1. Patients who had received a biopsy of breast lesion before the ultrasound examination

          2. Can not cooperate with the test operation

          3. Patients who were pregnant or lactating

          4. Patients who were undergoing neoadjuvant treatment.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Eligibility is based on gender</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin-Wu Cui, PhD,MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>You-Bin Deng, PhD,MD</last_name>
    <role>Study Chair</role>
    <affiliation>Tongji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li-Qiang Zhou, MD</last_name>
    <phone>15387076275</phone>
    <email>zlq_1118@hust.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xin-Wu Cui</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xin-Wu Cui, PhD,MD</last_name>
      <phone>15927103161</phone>
      <email>cuixinwu@live.cn</email>
    </contact>
    <contact_backup>
      <last_name>You-Bin Deng, PhD,MD</last_name>
      <phone>13871197838</phone>
      <email>ybdeng2007@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Choi JH, Kang BJ, Baek JE, Lee HS, Kim SH. Application of computer-aided diagnosis in breast ultrasound interpretation: improvements in diagnostic performance according to reader experience. Ultrasonography. 2018 Jul;37(3):217-225. doi: 10.14366/usg.17046. Epub 2017 Aug 14.</citation>
    <PMID>28992680</PMID>
  </results_reference>
  <results_reference>
    <citation>Kowal M, Filipczuk P, Obuchowicz A, Korbicz J, Monczak R. Computer-aided diagnosis of breast cancer based on fine needle biopsy microscopic images. Comput Biol Med. 2013 Oct;43(10):1563-72. doi: 10.1016/j.compbiomed.2013.08.003. Epub 2013 Aug 19.</citation>
    <PMID>24034748</PMID>
  </results_reference>
  <results_reference>
    <citation>Di Segni M, de Soccio V, Cantisani V, Bonito G, Rubini A, Di Segni G, Lamorte S, Magri V, De Vito C, Migliara G, Bartolotta TV, Metere A, Giacomelli L, de Felice C, D'Ambrosio F. Automated classification of focal breast lesions according to S-detect: validation and role as a clinical and teaching tool. J Ultrasound. 2018 Jun;21(2):105-118. doi: 10.1007/s40477-018-0297-2. Epub 2018 Apr 21.</citation>
    <PMID>29681007</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim K, Song MK, Kim EK, Yoon JH. Clinical application of S-Detect to breast masses on ultrasonography: a study evaluating the diagnostic performance and agreement with a dedicated breast radiologist. Ultrasonography. 2017 Jan;36(1):3-9. doi: 10.14366/usg.16012. Epub 2016 Apr 14.</citation>
    <PMID>27184656</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2019</study_first_posted>
  <last_update_submitted>March 23, 2019</last_update_submitted>
  <last_update_submitted_qc>March 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Xin-Wu Cui</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Artificial Intelligence; Ultrasound; Breast nodule; ECI</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Not public because of the personal information of the participants</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

